A trusted partner you can rely on
A trusted partner you can rely on
At Arcera, we collaborate with partners of all sizes to increase access to health and wellbeing solutions. Our flexible partnership model covers in-licensing, product acquisition, mergers and acquisitions (M&A), and joint ventures, creating shared, sustainable value.
We focus on high-impact, science-led therapeutic areas, including: Neurosciences, Cardiovascular & Metabolism, Gastroenterology, Infectious Diseases, Oncology, Pain and Rheumatology.
In collaboration with our partners, we accelerate innovation, bring breakthrough solutions to market faster, and deliver lasting benefits for patients and healthcare systems.
Let’s work together to expand our reach and impact.
0+
Active partnerships with
multinational pharma companies0+
Active partnerships with
established brand acquiers0+
Active partnerships with
mid- and small-size innovators
Why partner with us?
Broaden commercial access
Strong commercial platform across international markets leveraging our robust supply chain and market access capabilities.
Accelerate performance
Proven high-performance go-to-market capabilities and commercial excellence, utilizing local expertise and global reach.
Compliance and patient safety
Proven medical, regulatory and pharmacovigilance expertise, validated through successful audits and trusted by global partners and professional bodies.
At Arcera, we use our expertise in complex markets to meet the needs of a range of partners and keep progress happening.
Join us
We would be delighted to meet with you at the following congresses and exhibitions.
- CPHI
6-8 October, 2026
Milan, Italy
- Abu Dhabi Future Health Summit
20-22 October, 2026
Abu Dhabi, UAE
- BIO EUROPE
9-11 November, 2026
Cologne (Köln), Germany
- Jefferies
16-19 November, 2026
London, UK
Contact us today
Fill out this form to get in touch with us and discuss how we can collaborate.